Xinjiang public medical institution new crown virus nucleic acid testing single -person single exami

Tianshan News (Reporter Ren Chunxiang reported) From June 10, the autonomous region has adjusted the price of new crown virus nucleic acid detection and antigen detection prices in the autonomous region. Among them, the new crown virus nucleic acid testing single -person single -person single -person single -person single -person single -person single -person single -person per/person.

The reporter learned from the Medical Security Bureau of the Autonomous Region that in order to further reduce the large -scale screening and normal testing costs of the new coronary virus in the autonomous region, the Medical Real Estate Department of the Autonomous Region and the Corporation Medical Security Bureau and the New Crown Pneumonia Epidemic Prevention and Control Work Department issued the "Regarding the adjustment of the autonomous region and production and production Notice of the New Crown Virus Nucleic acid detection and antigen detection price of the Corporation (hereinafter referred to as the "Notice"), the new crown virus nucleic acid test (including testing agent) carried out by the public medical institution is up to 16 yuan/person, the new coronary virus nucleic acid Mixed detection (including testing agents) does not exceed 3.2 yuan per person.

The price of the new coronary virus antigen detection of the new coronary virus is maintained at 1 yuan/person. The price of antigen detection agents (including sample reagents) is zero -difference rate. The total amount of antigen detection prices and antigen detection agents (including sample equipment) is not higher than 5 yuan per person.

The government guidance price of the new coronal virus nucleic acid detection and antigen detection is the highest price limit. It does not distinguish between the level of public medical institutions. The actual charging standards of public medical institutions must not float, and it is unlimited.

The "Notice" requires that if a public medical institution conducts a new type of coronary virus nucleic acid testing services, two service options: single inspection and multi -person mixed inspection should be provided at the same time. Under the premise of meeting the epidemic prevention and control policy Registered fees, outpatient consultation fees, and general expenses of general diagnosis and treatment fees.

- END -